12:22 PM EST, 12/05/2024 (MT Newswires) -- Qualigen Therapeutics ( QLGN ) regained compliance with Nasdaq's minimum bid price and stockholders' equity requirements.

Nasdaq will monitor compliance for a year to ensure long-term compliance with listing requirements, Qualigen said Thursday in a statement.

Shares of the company fell 2.5% in recent Thursday trading.

Price: 4.63, Change: -0.12, Percent Change: -2.48